Press Release: Basilea launches the placement of -2-


Werte in diesem Artikel
Aktien

69.20 EUR 0.00 EUR 0.0 %

NOT BE PUBLICLY OFFERED OR SOLD IN THE UNITED STATES.

This communication does not constitute an "offer of securities to the

Werbung

public" within the meaning of Regulation 2017/1129 of the European Union

(the "Prospectus Regulation") of the securities referred to in it (the

"Securities") in any member state of the European Economic Area (the

"EEA"). Any offers of the Securities to persons in the EEA will be made

pursuant to an exemption under the Prospectus Regulation, as implemented

in member states of the EEA, from the requirement to produce a

Werbung

prospectus for offers of the Securities.

This communication expressly or implicitly contains certain

forward-looking statements concerning the Company and its business. Such

statements involve certain known and unknown risks, uncertainties and

other factors, which could cause the actual results, financial condition,

performance or achievements of the Company to be materially different

Werbung

from any future results, performance or achievements expressed or

implied by such forward-looking statements. The Company is providing

this communication as of this date and does not undertake to update any

forward-looking statements contained herein as a result of new

information, future events or otherwise.

For further information, please contact:

Peer Nils Schröder, PhD

Head of Corporate Communications & Investor Relations

Phone +41 61 606 1102

E-mail media_relations@basilea.com

investor_relations@basilea.com

This press release can be downloaded from www.basilea.com.

Attachment

-- Press release (PDF)

https://ml-eu.globenewswire.com/Resource/Download/cb6b6666-3513-40d6-8e54-3ff7539fb523

(END) Dow Jones Newswires

June 24, 2020 01:15 ET (05:15 GMT)

Aktuelle Basilea Pharmaceutica Aktie News

Werbung

Basilea Pharmaceutica Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Basilea Pharmaceutica nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
08.02.13 Basilea Pharmaceutica halten Vontobel Research
07.02.13 Basilea Pharmaceutica halten Vontobel Research
10.12.12 Basilea Pharmaceutica hold Vontobel Research
10.12.12 Basilea Pharmaceutica buy Sarasin Research
22.11.12 Basilea Pharmaceutica hold Vontobel Research

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.